P4 Clinical LLC
P4 Clinical LLC was paid $964K by Medicaid between Jan 2018 and Nov 2024, across 104 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 68% of everything it billed.
PINE BROOK, NJ 07058
Next to other Anatomic Pathology & Clinical Pathology Physician providers in New Jersey
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,893 | $6K | |
| 2019 | 1,970 | $4K | |
| 2020 | 19,062 | $369K | |
| 2021 | 25,640 | $442K | |
| 2022 | 9,889 | $16K | |
| 2023 | 29,947 | $66K | |
| 2024incomplete | 26,063 | $61K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 68% | 13,414 | 8,172 | $653K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 8.6% | 6,179 | 3,507 | $83K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 5.0% | 1,940 | 1,571 | $49K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.3% | 1,907 | 1,628 | $31K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.2% | 3,794 | 2,443 | $11K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.1% | 3,379 | 2,227 | $11K |
| 87481 | 1.1% | 1,601 | 1,277 | $11K | |
| 87506 | <1% | 420 | 356 | $9K | |
| 80061 | Lipid panel | <1% | 6,018 | 4,164 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,965 | 3,483 | $7K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 297 | 259 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,178 | 2,624 | $5K |
92 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,667 | $5K |
| 87150 | <1% | 149 | $5K | |
| 80053 | Comprehensive metabolic panel | <1% | 8,486 | $5K |
| 87556 | <1% | 1,452 | $4K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,487 | $4K |
| 82607 | <1% | 2,909 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,104 | $4K |
| 87640 | <1% | 1,597 | $4K | |
| 87653 | <1% | 1,519 | $4K | |
| 87563 | <1% | 1,467 | $3K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 763 | $3K |
| 80050 | General health panel | <1% | 485 | $3K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 67 | $2K |
| 82746 | <1% | 1,949 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 768 | $2K |
| 87529 | <1% | 276 | $2K | |
| 87500 | <1% | 922 | $2K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 478 | $2K |
| 84153 | <1% | 460 | $2K | |
| 83993 | <1% | 456 | $1K | |
| 87186 | <1% | 1,054 | $1K | |
| 88112 | <1% | 397 | $1K | |
| 84439 | <1% | 1,772 | $1K | |
| 88342 | <1% | 1,704 | $1K | |
| 87532 | <1% | 345 | $1K | |
| 87496 | <1% | 290 | $1K | |
| 87631 | <1% | 776 | $1K | |
| 87581 | <1% | 234 | $1K | |
| 84466 | <1% | 364 | $857.15 | |
| 82728 | <1% | 418 | $836.70 | |
| 87486 | <1% | 219 | $733.45 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,789 | $673.69 |
| 88313 | <1% | 1,387 | $660.62 | |
| 84702 | <1% | 129 | $659.29 | |
| 88312 | <1% | 1,266 | $633.19 | |
| 81001 | <1% | 1,878 | $359.64 | |
| 82656 | <1% | 298 | $343.01 | |
| 83540 | <1% | 436 | $335.36 | |
| 87511 | <1% | 174 | $253.60 | |
| 87541 | <1% | 59 | $233.90 | |
| 88142 | <1% | 61 | $214.49 | |
| 83001 | <1% | 145 | $212.81 | |
| 82705 | <1% | 180 | $203.22 | |
| 86803 | <1% | 116 | $182.00 | |
| 83630 | <1% | 110 | $180.83 | |
| 87641 | <1% | 136 | $174.23 | |
| 87077 | <1% | 324 | $157.68 | |
| 82043 | <1% | 263 | $127.57 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 32 | $118.64 |
| 87177 | <1% | 29 | $115.70 | |
| 87338 | <1% | 82 | $112.04 | |
| 82570 | <1% | 293 | $108.59 | |
| 84480 | <1% | 15 | $105.00 | |
| 87498 | <1% | 104 | $84.21 | |
| 83520 | <1% | 77 | $83.79 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 86 | $83.46 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 793 | $79.19 |
| 85730 | <1% | 106 | $56.83 | |
| 87209 | <1% | 14 | $53.44 | |
| 85610 | <1% | 155 | $52.70 | |
| 84481 | <1% | 24 | $45.50 | |
| 87340 | <1% | 43 | $43.42 | |
| 82274 | <1% | 31 | $41.40 | |
| 86800 | <1% | 32 | $40.00 | |
| 84550 | <1% | 77 | $36.12 | |
| 85045 | <1% | 13 | $31.08 | |
| 82670 | <1% | 14 | $27.94 | |
| 86140 | <1% | 22 | $27.38 | |
| 86900 | <1% | 89 | $25.55 | |
| 86901 | <1% | 89 | $25.55 | |
| 84144 | <1% | 13 | $23.09 | |
| 85652 | <1% | 68 | $21.37 | |
| 83615 | <1% | 44 | $20.12 | |
| 84146 | <1% | 13 | $19.38 | |
| 83002 | <1% | 14 | $18.52 | |
| 83735 | <1% | 110 | $16.57 | |
| 82248 | <1% | 12 | $15.09 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 506 | $12.32 |
| 83550 | <1% | 272 | $10.10 | |
| 87185 | <1% | 18 | $5.48 | |
| 84100 | <1% | 12 | $5.03 | |
| 86592 | <1% | 22 | $4.85 | |
| 80164 | 0% | 151 | $0.00 | |
| 85008 | 0% | 16 | $0.00 | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 0% | 594 | $0.00 |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | 0% | 260 | $0.00 |
| 85027 | 0% | 137 | $0.00 | |
| 80177 | 0% | 30 | $0.00 | |
| 84134 | 0% | 13 | $0.00 | |
| 84378 | 0% | 16 | $0.00 | |
| 88304 | 0% | 17 | $0.00 | |
| 84436 | 0% | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Theranostix INC | Beltsville, MD | $5.27M |
| Long Island Pathology INC | East Setauket, NY | $306K |
| Platinum Pathology, PLLC | Glen Allen, VA | $216K |
| Excel Medical Lab. INC | Edison, NJ | $150K |
| Theranostix INC | Indianapolis, IN | $8K |
| Metamark Laboratories, INC. | Augusta, GA | $569.11 |
| P4 Diagnostix LLC | Beltsville, MD | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.